Straight answers

Peptides: what's real, what's hype, and where the law stands

Peptides are everywhere right now, and a lot of what you're reading is marketing. Here's a straight answer about what they are, which ones are approved, and what we will and won't prescribe.

What a peptide actually is

A peptide is a short chain of amino acids — a signal that tells your cells what to do. Your body makes thousands of them. Insulin is one.

Some peptides have been studied carefully and turned into real medications. Others have barely been tested in people at all, and are being sold anyway.

You may already be taking one

GLP-1 medications are peptides. Semaglutide and Tirzepatide went through large human trials, so we know the dosing, the side effects, and the risks. That's why the brand-name versions are FDA-approved.

One thing we want to be clear about. We prescribe GLP-1s in both brand-name and compounded forms. Brand-name products are FDA-approved. Compounded versions are not — they're made by a licensed compounding pharmacy for one patient, and the FDA hasn't reviewed them. A lot of clinics blur that line. We won't. You'll always know which one you're getting.

The ones filling your feed

BPC-157, TB-500, MOTS-C, CJC-1295, and Ipamorelin are the ones you'll see promoted for healing, recovery, anti-aging, and performance.

None of them are FDA-approved for any use in people. That's not a paperwork delay. It means nobody has checked whether they're safe, whether they work, or whether what's in the vial matches the label.

"But a clinic near me prescribes it"

Some do. The rules here are genuinely confusing, which is part of why.

The short history: in 2023 the FDA flagged about 19 peptides over safety concerns, which took them off the table for compounding pharmacies. In April 2026 it lifted some of those flags. That got shared online as if the FDA had approved them. It didn't — they're still not cleared for pharmacies to compound.

And about that word "approved": even in the best case, these wouldn't become FDA-approved drugs. They'd become ingredients a pharmacy is allowed to work with.

Where Sermorelin is different

Sermorelin is a peptide we do prescribe, and the reason isn't arbitrary.

It was FDA-approved in 1997 and sold in the US as Geref. The manufacturer stopped making it in 2008 for business reasons, not safety, and the FDA has formally said so. That history is what lets pharmacies compound it today.

So the line for us isn't whether something is trending. It's whether there's a real safety record and a clear legal path.

Why we're cautious, and it isn't because we're behind

Wake Up Well exists so you understand what's happening in your body and what you're putting into it — what a medication does, why you're taking it, and what's still unknown. If we can't tell you that, we're not going to hand it to you and hope.

And if you're buying peptides online: anything labeled "research chemical" or "not for human consumption" hasn't been tested for sterility, purity, or dose. Nobody has checked what's in the vial.

What we do offer

• GLP-1 therapy for weight and metabolic health, when it's right for you — brand-name or compounded, explained clearly before you start.
• Sermorelin, when it fits your labs and your goals.
• A full root-cause workup. Fatigue, slow recovery, stubborn weight, and bad sleep are usually why people go looking for peptides. Often there's something measurable behind them: thyroid, iron, vitamin D, insulin resistance, or a hormone shift. We look first.
• A straight answer about anything you've read. Bring us the post or the podcast. We'll tell you what's known, what isn't, and where the line sits.

If that changes, you'll hear it from us

Some of these may eventually get a clear, legal path. We're watching. If that happens, we'll say so and explain what changed.

Until then, this page is what we actually think.